Litcius/Paper detail

Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis

Ujjwal Mukund Mahajan, Bettina Oehrle, Simon Sirtl, Ahmed Alnatsha, Elisabetta Goni, Ivonne Regel, Georg Beyer, Marlies Vornhülz, Jakob Vielhauer, Ansgar M. Chromik, Markus Bahra, Fritz Klein, Waldemar Uhl, Tim Fahlbusch, Marius Distler, Jürgen Weitz, Robert Grützmann, Christian Pilarsky, Frank Ulrich Weiß, Márk Ádám, John P. Neoptolemos, Holger Kalthoff, Roland Rad, Nicole Christiansen, Bianca Bethan, Beate Kamlage, Markus M. Lerch, Julia Mayerle

2022Gastroenterology46 citationsDOIOpen Access PDF

Topics & Concepts

Pancreatic cancerMedicinePancreatic ductal adenocarcinomaPancreatitisInternal medicineMalignancyOncologyCohortBiomarkerMetabolomicsAnalyteHepatocellular carcinomaCancerGastroenterologyBioinformaticsBiologyChemistryChromatographyBiochemistryPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentMetabolomics and Mass Spectrometry Studies
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis | Litcius